$3.3M HHS grant supports UTHealth Houston study on combination treatment strategy for pancreatic cancer

FHS
June 21, 2023
3:02 am

A combination strategy of endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) with chemotherapy for pancreatic cancer will be studied at UTHealth Houston through a $3.3 million grant from the National Cancer Institute by the U.S. Department of Health and Human Services.

Ipsen boards ADC train in $900M pact with Sutro

Ipsen has joined the global dealmaking spree for antibody-drug conjugates as the French biopharma picks up its first asset in oncology’s hottest pocket of R&D.

April 3, 2024

PsyBio Therapeutics Awarded Approval to Manufacture Biosynthetic Tryptamines at Scale | Psychedelic Finance

Oxford, Ohio and Denver, Colorado–(Newsfile Corp. – July 21, 2023) – PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) (“PsyBio” or the “Company“), an intellectual property

July 21, 2023

UCSF dementia experts to join peers at annual Clinical Trials on Alzheimer’s disease conference

Dementia experts from UC San Francisco will join their peers from around the globe at the annual Clinical Trials on Alzheimer’s Disease (CTAD) conference in

October 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.